Vanda Pharmaceuticals, Inc. (VNDA) Reports First Quarter 2013 Results
5/9/2013 6:54:40 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) to Announce First Quarter 2013 Financial Results on May 9, 2013
4/18/2013 6:46:54 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Appoints Dr. Paolo Baroldi as Chief Medical Officer
4/18/2013 6:44:38 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) to Present at the BioCentury Future Leaders in the Biotech Industry Conference
4/5/2013 6:46:19 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Reports Successful Completion of Pre-NDA Meeting With FDA on Tasimelteon for the Treatment of Non-24-Hour Disorder in the Totally Blind
3/25/2013 9:54:08 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Withdraws EU Filing for Schizophrenia Drug
3/15/2013 8:08:29 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) to Present at the Cowen and Company 33rd Annual Health Care Conference
2/28/2013 6:51:19 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Reports Fourth Quarter 2012 and Full Year 2012 Results
2/12/2013 6:25:01 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) to Stop Developing Anti-Depressant
1/31/2013 7:51:19 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Sleep Drug Effective in Second Late-Stage Trial
1/23/2013 7:02:12 AM
More...
|
|